Polycystic ovary syndrome is associated with P-wave prolongation and increased P-wave dispersion

References

• Scarpitta AM, Sinagra D. Polycystic ovary syndrome: an endocrine and metabolic disease. Gynecol Endocrinol 2000;14:392–5
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al; Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237–45
   PubMed Web of Science ®Google Scholar
• Zachurzok-Buczynska A, Szydlowski L, Gawlik A, et al. Blood pressure regulation and resting heart rate abnormalities in adolescent girls with polycystic ovary syndrome. Fertil Steril 2011;96:1519–25
   Google Scholar
• Yarali H, Yildirir A, Aybar F, et al. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 2001;76:511–6
   PubMed Web of Science ®Google Scholar
• Carmina E. Cardiovascular risk and events in polycystic ovary syndrome. Climateric 2009;12:22–5
   PubMed Web of Science ®Google Scholar
• Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992;37:119–25
   PubMed Web of Science ®Google Scholar
• Talbott E, Clerici A, Berga SL, et al. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 1998;51:415–22
   PubMed Web of Science ®Google Scholar
• Centurion OA. Clinical implications of the P wave duration and dispersion: relationship between atrial conduction defects and abnormally prolonged and fractionated atrial endocardial electrograms. Int J Cardiol 2009;134:6–8
   PubMed Web of Science ®Google Scholar
• Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733–8
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Google Scholar
• Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059--62
   Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9
   PubMed Web of Science ®Google Scholar
• Talbott EO, Zborowski JV, Sutton-Tyrrell K, et al. Cardiovascular risk in women with polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001;28:111–33
   PubMed Web of Science ®Google Scholar
• Wild RA. Long-term health consequences of PCOS. Hum Reprod Update 2002;8:231–41
   PubMed Web of Science ®Google Scholar
• Pierpoint T, McKeigue PM, Isaacs AJ, et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998;51:581–6
   PubMed Web of Science ®Google Scholar
• Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 2000;3:101–5
   PubMedGoogle Scholar
• de Groot PC, Dekkers OM, Romijn JA, et al. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update 2011;17:495–500
   PubMed Web of Science ®Google Scholar
• Shiber JR, Fontane E, Adewale A. Stroke registry: hemorrhagic vs ischemic strokes. Am J Emerg Med 2010;28:331–3
   PubMed Web of Science ®Google Scholar
• Parcharidis G. Stroke prevention in atrial fibrillation. Hellenic J Cardiol 2013;54:77
   Google Scholar
• Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719--47
   Google Scholar
• Yasar AS, Bilen E, Bilge M, et al. P-wave duration and dispersion in patients with metabolic syndrome. Pacing Clin Electrophysiol 2009;32:1168–72
   PubMed Web of Science ®Google Scholar
• Celik T, Yuksel UC, Bugan B, et al. P-wave dispersion and its relationship to aortic elasticity in young prehypertensive patients. Am J Hypertens 2009;22:1270–5
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774–800
   PubMed Web of Science ®Google Scholar
• Hudecova M, Holte J, Olovsson M, et al. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up. Fertil Steril 2011;96:1271–4
   PubMed Web of Science ®Google Scholar
• Dinh W, Lankisch M, Nickl W, et al. Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovasc Diabetol 2010;9:63
   PubMed Web of Science ®Google Scholar
• Kravariti M, Naka KK, Kalantaridou SN, et al. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:5088–95
   PubMed Web of Science ®Google Scholar
• Chamberlain AM, Agarwal SK, Ambrose M, et al. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2010;159:850–6
   PubMed Web of Science ®Google Scholar
• Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26:1565–74
   PubMed Web of Science ®Google Scholar
• Vasan RS, Levy D. The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview. Arch Intern Med 1996;156:1789–96
   PubMed Web of Science ®Google Scholar
• Tiras MB, Yalcin R, Noyan V, et al. Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome. Hum Reprod 1999;14:1949–52
   PubMed Web of Science ®Google Scholar